17-13017774-C-T

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_018127.7(ELAC2):​c.174G>A​(p.Val58Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00255 in 1,611,200 control chromosomes in the GnomAD database, including 136 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0026 ( 11 hom., cov: 32)
Exomes 𝑓: 0.0025 ( 125 hom. )

Consequence

ELAC2
NM_018127.7 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.00800
Variant links:
Genes affected
ELAC2 (HGNC:14198): (elaC ribonuclease Z 2) The protein encoded by this gene has a C-terminal domain with tRNA 3′ processing endoribonuclease activity, which catalyzes the removal of the 3' trailer from precursor tRNAs. The protein also interacts with activated Smad family member 2 (Smad2) and its nuclear partner forkhead box H1 (also known as FAST-1), and reduced expression can suppress transforming growth factor-beta induced growth arrest. Mutations in this gene result in an increased risk of prostate cancer. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.25).
BP6
Variant 17-13017774-C-T is Benign according to our data. Variant chr17-13017774-C-T is described in ClinVar as [Benign]. Clinvar id is 382955.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.008 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0525 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ELAC2NM_018127.7 linkc.174G>A p.Val58Val synonymous_variant Exon 1 of 24 ENST00000338034.9 NP_060597.4 Q9BQ52-1A0A0S2Z5M8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ELAC2ENST00000338034.9 linkc.174G>A p.Val58Val synonymous_variant Exon 1 of 24 1 NM_018127.7 ENSP00000337445.4 Q9BQ52-1

Frequencies

GnomAD3 genomes
AF:
0.00259
AC:
395
AN:
152248
Hom.:
11
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0580
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.00160
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000558
Gnomad OTH
AF:
0.00526
GnomAD3 exomes
AF:
0.00550
AC:
1275
AN:
231630
Hom.:
40
AF XY:
0.00495
AC XY:
631
AN XY:
127544
show subpopulations
Gnomad AFR exome
AF:
0.000217
Gnomad AMR exome
AF:
0.000325
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0618
Gnomad SAS exome
AF:
0.00170
Gnomad FIN exome
AF:
0.00165
Gnomad NFE exome
AF:
0.000799
Gnomad OTH exome
AF:
0.00283
GnomAD4 exome
AF:
0.00254
AC:
3712
AN:
1458834
Hom.:
125
Cov.:
31
AF XY:
0.00254
AC XY:
1846
AN XY:
725588
show subpopulations
Gnomad4 AFR exome
AF:
0.000149
Gnomad4 AMR exome
AF:
0.000225
Gnomad4 ASJ exome
AF:
0.0000768
Gnomad4 EAS exome
AF:
0.0696
Gnomad4 SAS exome
AF:
0.00164
Gnomad4 FIN exome
AF:
0.00199
Gnomad4 NFE exome
AF:
0.000380
Gnomad4 OTH exome
AF:
0.00434
GnomAD4 genome
AF:
0.00259
AC:
394
AN:
152366
Hom.:
11
Cov.:
32
AF XY:
0.00271
AC XY:
202
AN XY:
74506
show subpopulations
Gnomad4 AFR
AF:
0.0000481
Gnomad4 AMR
AF:
0.00131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.0579
Gnomad4 SAS
AF:
0.00104
Gnomad4 FIN
AF:
0.00160
Gnomad4 NFE
AF:
0.000573
Gnomad4 OTH
AF:
0.00520
Alfa
AF:
0.000727
Hom.:
0
Bravo
AF:
0.00287
Asia WGS
AF:
0.0260
AC:
91
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Apr 07, 2016
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Prostate cancer, hereditary, 2 Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Combined oxidative phosphorylation defect type 17 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:1
Jun 14, 2017
Mayo Clinic Laboratories, Mayo Clinic
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.25
CADD
Benign
13
DANN
Benign
0.97
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2286334; hg19: chr17-12921091; API